The accumulated data, clinically, shows that urinary amylase and urinary trypsinogen-2 are very sensitive and accurate indicators of AP, which is appropriate to identify the disease at an early stage, track its progression, and measure its severity. Here, PRSS2 is linked to alkaline phosphatase measurement.